Melatonin receptor 1B explained

Melatonin receptor 1B, also known as MTNR1B, is a protein that in humans is encoded by the MTNR1B gene.[1] [2]

Function

This gene encodes the MT2 protein, one of two high-affinity forms of a receptor for melatonin, the primary hormone secreted by the pineal gland. This gene product is an integral membrane protein that is a G-protein coupled, 7-transmembrane receptor. It is found primarily in the retina and brain; however, this detection requires RT-PCR. It is thought to participate in light-dependent functions in the retina and may be involved in the neurobiological effects of melatonin.[1] Besides the brain and retina this receptor is expressed on the bone forming cells where it regulates their function in depositing bone.[3]

Clinical significance

Several studies have identified MTNR1B receptor mutations that are associated with increased average blood sugar level and around a 20 percent elevated risk of developing type 2 diabetes.[4] [5] [6] MTNR1B mRNA is expressed in human islets, and immunocytochemistry confirms that it is primarily localized in beta cells in islets.

Ligands

The following MT2R ligands have selectivity over MT1R:

See also

Further reading

External links

Notes and References

  1. Web site: Entrez Gene: MTNR1B melatonin receptor 1B.
  2. Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF . Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor . Proceedings of the National Academy of Sciences of the United States of America . 92 . 19 . 8734–38 . Sep 1995 . 7568007 . 41041 . 10.1073/pnas.92.19.8734 . 1995PNAS...92.8734R . free .
  3. Sharan K, Lewis K, Furukawa T, Yadav VK . Regulation of bone mass through pineal-derived melatonin-MT2 pathway . . 79A . 2 . 263–270 . 28512916 . 5575491 . 10.1111/jpi.12423. 2006 .
  4. Web site: Gene That Regulates Glucose Levels And Increases Risk For Diabetes Identified . 2008-06-28 . ScienceDaily . 2009-01-18.
    Web site: Body Clock Linked To Diabetes And High Blood Sugar In New Genome-wide Study . 2008-12-08 . ScienceDaily . 2009-01-18. ; Web site: Is There A Relationship Between Sleep-wake Rhythm And Diabetes? A New Gene Variant Influences Fasting Glucose Levels Via The Melatonin Metabolism . 2009-01-16 . ScienceDaily . 2009-01-18.
  5. Prokopenko I, Langenberg C, Florez JC, Saxena R, Soranzo N, Thorleifsson G, Loos RJ, Manning AK, Jackson AU, Aulchenko Y, Potter SC, Erdos MR, Sanna S, Hottenga JJ, Wheeler E, Kaakinen M, Lyssenko V, Chen WM, Ahmadi K, Beckmann JS, Bergman RN, Bochud M, Bonnycastle LL, Buchanan TA, Cao A, Cervino A, Coin L, Collins FS, Crisponi L, de Geus EJ, Dehghan A, Deloukas P, Doney AS, Elliott P, Freimer N, Gateva V, Herder C, Hofman A, Hughes TE, Hunt S, Illig T, Inouye M, Isomaa B, Johnson T, Kong A, Krestyaninova M, Kuusisto J, Laakso M, Lim N, Lindblad U, Lindgren CM, McCann OT, Mohlke KL, Morris AD, Naitza S, Orrù M, Palmer CN, Pouta A, Randall J, Rathmann W, Saramies J, Scheet P, Scott LJ, Scuteri A, Sharp S, Sijbrands E, Smit JH, Song K, Steinthorsdottir V, Stringham HM, Tuomi T, Tuomilehto J, Uitterlinden AG, Voight BF, Waterworth D, Wichmann HE, Willemsen G, Witteman JC, Yuan X, Zhao JH, Zeggini E, Schlessinger D, Sandhu M, Boomsma DI, Uda M, Spector TD, Penninx BW, Altshuler D, Vollenweider P, Jarvelin MR, Lakatta E, Waeber G, Fox CS, Peltonen L, Groop LC, Mooser V, Cupples LA, Thorsteinsdottir U, Boehnke M, Barroso I, Van Duijn C, Dupuis J, Watanabe RM, Stefansson K, McCarthy MI, Wareham NJ, Meigs JB, Abecasis GR . 6 . Variants in MTNR1B influence fasting glucose levels . Nature Genetics . 41 . 1 . 77–81 . Jan 2009 . 19060907 . 2682768 . 10.1038/ng.290 .
    Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spégel P, Bugliani M, Saxena R, Fex M, Pulizzi N, Isomaa B, Tuomi T, Nilsson P, Kuusisto J, Tuomilehto J, Boehnke M, Altshuler D, Sundler F, Eriksson JG, Jackson AU, Laakso M, Marchetti P, Watanabe RM, Mulder H, Groop L . 6 . Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion . Nature Genetics . 41 . 1 . 82–88 . Jan 2009 . 19060908 . 10.1038/ng.288 . 3725650 . ; Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, Sparsø T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Lévy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P . 6 . A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk . Nature Genetics . 41 . 1 . 89–94 . Jan 2009 . 19060909 . 10.1038/ng.277 . 205347673 .
  6. Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, Guthoff M, Silbernagel G, Stefan N, Häring HU, Fritsche A . Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function . PLOS ONE . 3 . 12 . e3962 . 2008 . 19088850 . 2597741 . 10.1371/journal.pone.0003962 . 2008PLoSO...3.3962S . Maedler . Kathrin . free .
  7. Gabriella Gobbi . Rivara S, Lodola A, Mor M, Bedini A, Spadoni G, Lucini V, Pannacci M, Fraschini F, Scaglione F, Sanchez RO, Gobbi G, Tarzia G . N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands . Journal of Medicinal Chemistry . 50 . 26 . 6618–26 . Dec 2007 . 18052314 . 10.1021/jm700957j . 11576/1886829 . free .
  8. Bedini A, Spadoni G, Gatti G, Lucarini S, Tarzia G, Rivara S, Lorenzi S, Lodola A, Mor M, Lucini V, Pannacci M, Scaglione F . Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands . Journal of Medicinal Chemistry . 49 . 25 . 7393–403 . Dec 2006 . 17149869 . 10.1021/jm060850a .
  9. Yous S, Durieux-Poissonnier S, Lipka-Belloli E, Guelzim H, Bochu C, Audinot V, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D . Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands . Bioorganic & Medicinal Chemistry . 11 . 5 . 753–59 . Mar 2003 . 12538005 . 10.1016/S0968-0896(02)00473-X .
  10. Mattson RJ, Catt JD, Keavy D, Sloan CP, Epperson J, Gao Q, Hodges DB, Iben L, Mahle CD, Ryan E, Yocca FD . Indanyl piperazines as melatonergic MT2 selective agents . Bioorganic & Medicinal Chemistry Letters . 13 . 6 . 1199–202 . Mar 2003 . 12643943 . 10.1016/S0960-894X(03)00090-8 .